This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
2 Therefore, early identification of HF in high-risk populations, particularly post-MI, is essential for improving outcomes. Common predictors include older age, prior hypertension, diabetes and atrialfibrillation. Risk factors for developing HF after MI vary and are influenced by whether the patient has HFrEF or HFpEF.
The term ‘epidemic’ is increasingly used to describe the rising global prevalence of atrialfibrillation (AF). Indeed, numerous studies are currently investigating the impact of such approaches on clinical outcomes and healthcare utilisation. Recent estimates suggest that AF accounts for between 0.9% 2 Before the.
Background: Patients with atrialfibrillation (AF) and concomitant pulmonary hypertension (pHTN) have an increased risk of morbidity and mortality. However, the outcomes of catheter ablation in this cohort are unclear.
million Americans have atrialfibrillation. Atrialfibrillation, a rapid, irregular heart beat that can lead to stroke or sudden death, is three times more common than previously thought, affecting nearly 5 percent of the population, or 10.5 tim.hodson Wed, 09/11/2024 - 15:40 Sept. million U.S. million U.S.
Rate vs Rhythm Control in AtrialFibrillation Rate vs rhythm control as a management strategy in atrialfibrillation has been a long standing topic for debate. EAST-AFNET 4 trial had 2789 patients with early atrialfibrillation and cardiovascular conditions [8]. years of follow up per patient.
Hypertension is the single most important risk factor for development of atrialfibrillation (AF), which may be considered as a cardiac manifestation of hypertensive target organ damage. Furthermore, coexistence of hypertension and AF mutually amplifies the risk of complications, such as heart failure and stroke.
BackgroundMultimorbidity is common among patients with atrialfibrillation (AF) and is associated with worse outcomes. Multimorbidity was defined as 2 comorbidities (heart failure, hypertension, diabetes, coronary heart disease, kidney dysfunction, moderate or severe mitral valve regurgitation, or obesity).
CTA and the ACC recognize there is strong potential for cardiac monitoring (through Consumer Cardiovascular Technology Solutions) to help identify and screen patients with AtrialFibrillation (AFib) and related arrhythmias to alert the right clinical groups for early support and reduction in mortality rates.
Background:Atrial fibrillation (AF) during pregnancy and puerperium is devastating for the mother and her family, yet data regarding incidence and outcomes are very limited.Objective:We aimed to investigate the incidence and outcomes of AF during pregnancy and puerperium in a large database. P< 0001).
Background:Pulmonary hypertension (PH) and secondary right ventricle dysfunction is present in 20% of adults with coarctation of aorta (COA) based on echocardiographic studies. per 1 ml/mmHg), left atrial reservoir strain (adjusted OR 0.95, 95% CI 0921-0.98 per 1%), and atrialfibrillation (adjusted OR 2.18, 95% CI 1.20-13.5).
Publication date: Available online 30 November 2023 Source: The American Journal of Cardiology Author(s): Muni Rubens, Venkataraghavan Ramamoorthy, Anshul Saxena, Javier Jimenez, Shebin George, Jiana Baker, Juan Ruiz, Sandra Chaparro
Migraine with aura(MwA) is associated with an increased risk of stroke and adverse vascular outcomes compared to those with migraine without aura (MwoA). AI-ECG prediction models developed at our institution can evaluate the probability of atrialfibrillation (AF) and estimate a patients age based on a normal sinus rhythm (NSR) ECG.
Objective The European Society of Cardiology guidelines have recently defined new cut-offs for pulmonary hypertension (PH) and pulmonary vasculature resistance (PVR; median pulmonary artery pressure (mPAP) >20 instead of 25 mm Hg and PVR >2 instead of 3 Wood unit). Overall median age was 82 years, while 55.3% patients were male.
Hypertension, Ahead of Print. After quality assessment and data extraction, meta-analyses were performed to generate pooled estimates of the association (hazard ratios) between TTR and health outcomes. Primary outcomes were all-cause mortality and cardiovascular death.
BackgroundHypertension is common and leads to negative outcomes. Intensive blood pressure (BP) lowering can reduce cardiovascular events and allcause mortality, but its benefits for patients with hypertension with multiple comorbidities are uncertain.
Obesity significantly increases AF risk, both directly and indirectly, through related conditions, like hypertension, diabetes, and heart failure. AF increases the risk of stroke, heart failure, dementia, and hospitalization. However, studies on how obesity affects pharmacologic or interventional AF treatments are limited.
million Americans have atrialfibrillation. Atrialfibrillation, a rapid, irregular heart beat that can lead to stroke or sudden death, is three times more common than previously thought, affecting nearly 5 percent of the population, or 10.5 tim.hodson Wed, 09/11/2024 - 15:40 Sept. million U.S. million U.S.
Introduction:Intracranial hemorrhage (ICH) is the most severe adverse effect of anticoagulation in atrialfibrillation (AF) patients. Hypertension, diabetes, hyperlipidemia, and chronic kidney disease are well-known cardiovascular risk factors for ICH. Stroke, Volume 56, Issue Suppl_1 , Page A49-A49, February 1, 2025.
The primary outcome was a composite of inhospital adverse events. Associations between multimorbidity patterns and outcomes were evaluated using multivariableadjusted logistic regression models. years]) admitted to the China Chest Pain Center Database between 2016 and 2021. Among 9570 patients, 50% (n=4789) had multimorbidity.
September is National AtrialFibrillation (AFib) Awareness Month, a time dedicated to raising awareness about one of the most common yet often misunderstood heart conditions. Understanding AtrialFibrillationAtrialFibrillation is characterized by an irregular and often rapid heart rhythm that can lead to poor blood flow.
Arrhythmias: Genetic mutations can also predispose individuals to irregular heart rhythms, such as atrialfibrillation or long QT syndrome, which may increase the risk of stroke or sudden cardiac arrest. Mutations in specific genes often cause hypertrophic cardiomyopathy and dilated cardiomyopathy.
Diabetes is a risk factor for acute ischemic stroke and also a poor predictor of outcome for many interventional surgeries. vs 45.3%, p=0.05) after adjusting for age, NIHSS, and atrialfibrillation. vs 45.3%, p=0.05) after adjusting for age, NIHSS, and atrialfibrillation. or greater.
Beta-blocker use and outcomes in patients with HFmrEF/HFpEF. In the absence of evidence from randomized trials, we conducted an observational analysis of outcomes among 16951 beta-blocker users and non-users in four large HFmrEF/HFpEF trials (I-Preserve, TOPCAT, PARAGON-HF, and DELIVER).
Background:Anticoagulation (AC) in patients with atrialfibrillation (AF) at high risk for stroke is strongly recommended in guidelines, but tracking the optimal use of AC at scale and across hospital systems is challenging due to the need to examine both thrombotic and bleeding risks that often factor in clinical decisions.
Clinical outcomes are reported in a non-randomized fashion from enrolment and from the end of the trial. The primary outcome was relapse defined as 10% reduction in left ventricular ejection fraction to 400ng/L, or clinical features of heart failure.
This blog explores the ways wearable technology can help track heart health, the advantages it offers, and how it contributes to better outcomes for those requiring surgical intervention. The Role of Wearable Technology in Heart Health Wearable tech is designed to monitor physiological data and provide actionable insights to users.
September is National AtrialFibrillation (AFib) Awareness Month, a time dedicated to raising awareness about one of the most common yet often misunderstood heart conditions. Understanding AtrialFibrillationAtrialFibrillation is characterized by an irregular and often rapid heart rhythm that can lead to poor blood flow.
Propensity score-matched analysis (PSM) (1:1) was performed with matching for age, gender, race, BMI, hypertension, diabetes mellitus, chronic kidney disease, hemoglobin level, low-density lipid (LDL) level, left ventricular ejection fraction, and various drugs including ACEi, ARBi, ARNI, beta-blockers, and diuretics. years, with 49.27% men.
Background:The STRACK project aims to improve post-stroke patient management and the transition from acute to primary care thanks to improvements in patient pathways and monitoring cardiovascular risk factors: heart failure, diabetes, atrialfibrillation, dyslipidemia and hypertension.
Previous studies showed considerable risks of outcomes in this group. In this study, we aimed to investigate the long-term outcomes in very young patients with MINOCA. They had significantly lower rates of diabetes and hypertension and higher rates of male gender and smoking compared to the older group.
vs 63.38, p<0.001) and had fewer comorbidities such as cancer and chronic kidney disease, atrialfibrillation, hypertension, hyperlipidemia. We observed an increasing trend of ICH among pregnant individuals. Pregnant patients were notably younger (30.63 vs 16.2%, p<0.001). vs 23.2%, p<0.001).
Objectives We aim to assess the association of cardiovascular medications with outcomes of patients referred to the diagnostic heart failure (HF) clinic with symptoms or signs of possible HF, raised N-terminal pro-brain-type natriuretic peptide (NT-proBNP) but no evidence of HF on transthoracic echocardiography (TTE). to 0.97; p=0.02).
This year’s theme, “Advancing Cardiovascular Care for All” brings the latest practice-changing breakthroughs, along with top experts debating and discussing outcomes of highly-anticipated clinical trials. 24 from April 6 - 8, 2024 in Atlanta, GA at the Georgia World Congress Center. The Guidelines Sessions at ACC.24
However, limited studies have compared their clinical features and outcomes. vs. 8.7%), atrialfibrillation (6.1% vs. 3.7%), hypertension (58.0% These findings advocate for tailored treatment strategies based on dissection type to optimize patient outcomes. 1.69, P=0.480) (Figure).Conclusion:Our
Introduction:Clinical characteristics of patients with in-hospital onset stroke (IHOS) compared to those with out-of-hospital onset stroke are reported to be late detection of stroke onset, less use of rt-PA, presence of atrialfibrillation, and poor outcome. Stroke group had higher mortality (14.9%
We assessed the rate, characteristics, risk factors and survival outcomes of perioperative stroke following surgical resection of glioma.Design:This is a retrospective chart review of a single quaternary care center of patients with glioma between 2005-2021 who underwent resection. Patients who had a stroke were older [mean (SD); 60.4
Arrhythmias, and in particular atrialfibrillation (AF), are one of the greatest healthcare challenges of our time. Arrhythmia prediction models have long relied on conventional risk factors such as age, diabetes, hypertension, and history of myocardial infarction and heart failure.
A nightly sleep duration less than 6 hours per night appears to be especially detrimental, but some studies have even shown worse health outcomes for adults sleeping 7 hours or less compared to those sleeping the recommended 7–9 hours per night. The impact of optimizing circadian biology on health cannot be understated.
Hypertension, Volume 80, Issue 12 , Page 2572-2580, December 1, 2023. BACKGROUND:The STEP (Strategy of Blood Pressure Intervention in the Elderly Hypertensive Patients) trial demonstrated that intensive systolic blood pressure (SBP) lowering has cardiovascular benefits. years, and 46.5% years, and 46.5%
Background:Cancer is associated with an increased risk for atrialfibrillation. However, there are no existing data supporting an independent relationship between cancer and atrial cardiopathy, another atrial pathology associated with increased acute ischemic stroke (AIS) risk. The study exposure was active cancer.
Smith Center for Outcomes Research in Cardiology and director of the cardiac critical care unit at Beth Israel Deaconess Medical Center in Boston, Mass. Kazi , vice chair of the advisory writing group, said in an AHA news release. Kazi is head of health economics and associate director of the Richard A. and Susan F.
New guidelines also: Classify “Elevated BP” between non-elevated BP and hypertension. Measuring eGFR and albuminuria is recommended for assessing kidney disease in all hypertensive patients. Advise increased potassium intake for hypertensive patients. Watch here!
Then identified clusters are predicted and tested in the learning set to evaluate their association with outcomes. Clusters were significantly associated with outcomes in derivation and validation datasets, with Cluster 1 having the highest risk, and Cluster 4 the lowest.
Atrialfibrillation is also a predictor of worse outcomes in this case (Alborzi). Q waves in association with RBBB are usually not seen in anterior leads unless there is pulmonary hypertension or anterior infarction. RBBB in blunt chest trauma seems to be indicative of several RV injury.
We organize all of the trending information in your field so you don't have to. Join thousands of users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content